Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

11 structures for Q8NI22

Entry ID Method Resolution Chain Position Source
2VRG NMR - A 27-146 PDB
3A4U X-ray 184 A B 27-146 PDB
3LCP X-ray 245 A C/D 58-146 PDB
3WHT X-ray 180 A B 67-146 PDB
3WHU X-ray 260 A B 67-146 PDB
3WNX X-ray 275 A B 67-146 PDB
4YGB X-ray 160 A B/D 67-146 PDB
4YGC X-ray 240 A B/D/F/H 67-146 PDB
4YGD X-ray 251 A B/D/F/H 67-146 PDB
4YGE X-ray 305 A B/D/F 27-146 PDB
AF-Q8NI22-F1 Predicted AlphaFoldDB

158 variants for Q8NI22

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000985001
rs1572611822
CA346712610
16 L>P Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV000003001
rs1253799389
35 Q>missing Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinVar
dbSNP
rs756021929
RCV000316889
CA10613552
36 P>A Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000294495
CA10615717
rs886056118
79 M>T Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs78289603
CA46626204
VAR_072245
81 D>H F5F8D2 [UniProt] Yes ClinGen
UniProt
Ensembl
dbSNP
rs78289603
RCV000003006
CA115804
81 D>Y Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV000003002
rs1294221028
RCV001580061
83 D>missing Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinVar
dbSNP
rs1558461545
RCV000003003
89 D>missing Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinVar
dbSNP
CA1646858
rs768388209
RCV001137002
121 I>M Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000851982
rs1484184249
127 D>missing Factor V and factor VIII, combined deficiency of, type 1 [ClinVar] Yes ClinVar
dbSNP
VAR_019076
CA115788
RCV000003004
rs137852913
129 D>E Factor 5 and Factor VIII, combined deficiency of, 2 F5F8D2; interferes with protein folding [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs748641905
CA1646850
VAR_072246
135 Y>N F5F8D2 [UniProt] Yes ClinGen
UniProt
ExAC
dbSNP
gnomAD
rs137852914
CA115796
VAR_019077
RCV000003005
136 I>T Factor 5 and Factor VIII, combined deficiency of, 2 F5F8D2; interferes with protein folding [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
dbSNP
rs80294301
CA1646840
RCV000330681
RCV001270570
139 A>V Factor 5 and Factor VIII, combined deficiency of, 2 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA346712689
rs1254106218
3 M>T No ClinGen
gnomAD
rs900041651
CA46626922
3 M>V No ClinGen
TOPMed
gnomAD
rs777983162
CA1646986
5 S>F No ClinGen
ExAC
gnomAD
CA346712674
rs777983162
5 S>Y No ClinGen
ExAC
gnomAD
CA1646985
rs371098791
6 L>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1297497901
CA346712671
6 L>V No ClinGen
gnomAD
rs1454584927
CA346712658
8 R>S No ClinGen
gnomAD
CA1646982
rs755090937
8 R>T No ClinGen
ExAC
gnomAD
rs1005839493
CA46626903
9 T>I No ClinGen
TOPMed
CA346712653
rs1005839493
9 T>N No ClinGen
TOPMed
CA346712655
rs1572611879
9 T>P No ClinGen
Ensembl
CA346712648
rs1172452105
10 P>H No ClinGen
TOPMed
gnomAD
CA346712646
rs1172452105
10 P>L No ClinGen
TOPMed
gnomAD
CA346712631
rs1375324203
13 C>R No ClinGen
TOPMed
gnomAD
rs11555002
CA46626889
14 G>C No ClinGen
gnomAD
CA346712624
rs11555002
14 G>S No ClinGen
gnomAD
CA346712602
rs1183830132
17 W>C No ClinGen
gnomAD
CA1646977
rs767223303
17 W>S No ClinGen
ExAC
gnomAD
CA346712590
rs1176879847
19 F>S No ClinGen
TOPMed
rs1163253991
CA346712577
21 A>T No ClinGen
gnomAD
rs768254017
COSM575540
CA1646974
22 P>L lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA1646975
rs773962348
22 P>S No ClinGen
ExAC
rs777188077
CA1646972
23 G>S No ClinGen
ExAC
gnomAD
rs937344425
CA46626860
24 A>D No ClinGen
Ensembl
CA346712563
rs747338625
24 A>P No ClinGen
ExAC
TOPMed
gnomAD
rs747338625
CA1646970
24 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 24 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1646969
rs201005763
25 R>G No ClinGen
1000Genomes
ExAC
gnomAD
rs1248468378
CA346712550
26 A>G No ClinGen
gnomAD
rs1338731005
CA346712540
27 E>D No ClinGen
gnomAD
rs772241915
CA1646968
28 E>* No ClinGen
ExAC
TOPMed
gnomAD
rs772241915
CA46626852
28 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1392087938
CA346712530
29 P>R No ClinGen
TOPMed
gnomAD
CA46626843
rs927338670
29 P>S No ClinGen
TOPMed
CA46626846
rs927338670
29 P>T No ClinGen
TOPMed
rs879024913
CA46626837
30 A>G No ClinGen
TOPMed
gnomAD
rs748338168
CA1646967
30 A>T No ClinGen
ExAC
gnomAD
rs1429442154
CA346712525
31 A>P No ClinGen
gnomAD
CA346712519
rs1386263684
32 S>G No ClinGen
gnomAD
CA1646966
rs779155851
32 S>I No ClinGen
ExAC
gnomAD
CA346712510
rs1366396078
33 F>V No ClinGen
gnomAD
CA1646964
rs749396379
34 S>F No ClinGen
ExAC
gnomAD
rs376476823
CA346712493
35 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs756021929
CA1646962
36 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs201137824
CA46626814
37 G>S No ClinGen
1000Genomes
TOPMed
rs1462774767
CA346712479
38 S>N No ClinGen
TOPMed
rs757163409
CA1646958
39 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA46626808
rs757163409
39 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA346712467
rs1450160438
40 G>S No ClinGen
TOPMed
rs1188837024
CA346712459
41 L>P No ClinGen
TOPMed
rs141927904
CA1646957
42 D>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1646956
rs763902751
43 K>E No ClinGen
ExAC
gnomAD
rs534474434
CA46626787
44 N>S No ClinGen
1000Genomes
TOPMed
gnomAD
rs762456312
CA1646955
45 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA1646953
rs774875101
46 V>A No ClinGen
ExAC
gnomAD
rs761116621
CA1646951
47 H>D No ClinGen
ExAC
gnomAD
rs778325740
CA1646950
47 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA346712412
rs1470147097
48 D>E No ClinGen
gnomAD
rs1162286700
COSM1532215
CA346712418
48 D>H lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA346712419
rs1162286700
48 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs369431266
CA1646947
50 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1436617131
CA346712401
50 E>K No ClinGen
TOPMed
CA346712378
rs1558461744
51 H>L No ClinGen
Ensembl
rs775825745
CA1646926
52 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs558502042
CA1646925
53 M>I No ClinGen
1000Genomes
ExAC
gnomAD
CA346712355
rs1325851793
54 E>D No ClinGen
TOPMed
CA46626262
rs543577609
54 E>Q No ClinGen
1000Genomes
CA1646924
rs746007921
57 E>D No ClinGen
ExAC
gnomAD
rs1221772963
CA346712337
57 E>G No ClinGen
TOPMed
rs192820723
CA1646923
59 V>A No ClinGen
1000Genomes
ExAC
gnomAD
CA1646922
rs771003004
61 N>H No ClinGen
ExAC
gnomAD
CA1646921
rs138519672
61 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1646919
rs777741288
63 P>S No ClinGen
ExAC
gnomAD
rs914718297
CA46626248
64 E>Q No ClinGen
gnomAD
CA346712286
rs200415122
65 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs200415122
CA1646918
65 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1646916
rs778684574
66 E>D No ClinGen
ExAC
gnomAD
TCGA novel 66 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1412721285
CA346712284
66 E>Q No ClinGen
TOPMed
gnomAD
COSM3426483
CA1646915
rs754442571
68 S>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA46626234
rs535874558
69 P>S No ClinGen
1000Genomes
rs137964402
CA1646911
73 Q>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA346712235
rs137964402
73 Q>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1239316807
CA346712226
74 L>H No ClinGen
TOPMed
gnomAD
rs1239316807
CA346712225
74 L>P No ClinGen
TOPMed
gnomAD
CA346712184
rs1156867409
77 F>Y No ClinGen
TOPMed
rs764322613
CA1646908
79 M>I No ClinGen
ExAC
gnomAD
rs751887064
CA1646909
79 M>L No ClinGen
ExAC
gnomAD
CA346712127
rs763394078
80 H>D No ClinGen
ExAC
gnomAD
rs763394078
CA1646907
80 H>Y No ClinGen
ExAC
gnomAD
CA346712093
rs1294877068
82 Y>C No ClinGen
gnomAD
rs1359783243
CA346712048
85 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs775513362
CA346712006
88 L>P No ClinGen
ExAC
gnomAD
rs775513362
CA1646906
88 L>R No ClinGen
ExAC
gnomAD
CA346712014
rs1458296838
88 L>V No ClinGen
gnomAD
rs994703366
CA46626189
90 G>A No ClinGen
TOPMed
CA346711980
rs994703366
90 G>D No ClinGen
TOPMed
rs1379217647
CA346711985
90 G>S No ClinGen
gnomAD
CA346711968
rs1304048981
91 L>F No ClinGen
gnomAD
CA346711952
rs1572609626
92 E>D No ClinGen
Ensembl
rs1445238415
CA346711944
93 L>F No ClinGen
gnomAD
CA1646905
rs770123754
95 T>I No ClinGen
ExAC
gnomAD
rs759679044
CA1646904
96 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1572609585
CA346711877
99 H>D No ClinGen
Ensembl
rs79211648
CA46626171
100 V>D No ClinGen
Ensembl
CA1646901
rs746904307
101 H>P No ClinGen
ExAC
TOPMed
gnomAD
rs746904307
CA1646902
101 H>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1168152311
CA346711850
101 H>Y No ClinGen
gnomAD
CA346710858
rs1175457096
106 S>N No ClinGen
gnomAD
rs1366185198
CA346710852
106 S>R No ClinGen
gnomAD
CA46624849
rs950948431
109 A>T No ClinGen
TOPMed
gnomAD
CA46624843
rs373893031
111 L>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs765195770
CA46624837
111 L>P No ClinGen
Ensembl
rs373893031
CA46624845
111 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel
rs1467999949
CA346710782
112 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
gnomAD
NCI-TCGA
CA1646863
rs370788387
112 M>T No ClinGen
ESP
ExAC
gnomAD
rs141584198
CA1646862
114 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs767334331
CA1646861
115 D>G No ClinGen
ExAC
gnomAD
TCGA novel 116 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1199851863
CA346710717
117 L>V No ClinGen
TOPMed
rs199922892
CA1646860
118 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA1646859
rs774183668
120 I>L No ClinGen
ExAC
gnomAD
rs774183668
CA46624801
120 I>V No ClinGen
ExAC
gnomAD
TCGA novel 121 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
RCV001270559
rs1668185105
122 D>N No ClinVar
dbSNP
rs775052308
CA1646856
123 G>C No ClinGen
ExAC
TOPMed
gnomAD
rs1257293550
CA346710601
125 L>F No ClinGen
TOPMed
CA46624793
rs967209929
125 L>M No ClinGen
gnomAD
rs769498395
CA1646855
128 D>E No ClinGen
ExAC
TCGA novel 129 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 129 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA46624784
rs201153154
132 N>D No ClinGen
1000Genomes
CA1646854
rs745351183
132 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA1646851
rs747447570
135 Y>L No ClinGen
ExAC
gnomAD
CA1646848
rs779577150
136 I>V No ClinGen
ExAC
gnomAD
TCGA novel 137 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs80294301
CA1646841
139 A>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs148748272
CA1646843
139 A>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs148748272
CA1646842
139 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs761817833
CA1646839
142 A>G No ClinGen
ExAC
gnomAD
rs868709713
CA46624723
142 A>T No ClinGen
Ensembl
rs764018345
CA1646837
146 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA46624709
rs765992456
146 Q>K No ClinGen
TOPMed
gnomAD
rs751451785
CA1646838
146 Q>R No ClinGen
ExAC
gnomAD

1 associated diseases with Q8NI22

[MIM: 613625]: Factor V and factor VIII combined deficiency 2 (F5F8D2)

A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:12717434, ECO:0000269|PubMed:18590741, ECO:0000269|PubMed:18685427, ECO:0000269|PubMed:20491958}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:12717434, ECO:0000269|PubMed:18590741, ECO:0000269|PubMed:18685427, ECO:0000269|PubMed:20491958}. Note=The disease is caused by variants affecting the gene represented in this entry.

1 regional properties for Q8NI22

Type Name Position InterPro Accession
domain Synaptotagmin-like mitochondrial-lipid-binding domain 1 - 195 IPR031468

Functions

Description
EC Number
Subcellular Localization
  • Endoplasmic reticulum-Golgi intermediate compartment
  • Endoplasmic reticulum
  • Golgi apparatus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
endoplasmic reticulum-Golgi intermediate compartment membrane The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.
ER to Golgi transport vesicle membrane The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.

1 GO annotations of molecular function

Name Definition
calcium ion binding Binding to a calcium ion (Ca2+).

2 GO annotations of biological process

Name Definition
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
vesicle-mediated transport A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8K5B2 Mcfd2 Multiple coagulation factor deficiency protein 2 homolog Mus musculus (Mouse) PR
Q8K5B3 Mcfd2 Multiple coagulation factor deficiency protein 2 homolog Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MTMRSLLRTP FLCGLLWAFC APGARAEEPA ASFSQPGSMG LDKNTVHDQE HIMEHLEGVI
70 80 90 100 110 120
NKPEAEMSPQ ELQLHYFKMH DYDGNNLLDG LELSTAITHV HKEEGSEQAP LMSEDELINI
130 140
IDGVLRDDDK NNDGYIDYAE FAKSLQ